Regencell Bioscience Holdings Limited
RGC
Rank in Stocks
#3564
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Share Price
$9.69
Last synced: 2026-10-16
Market Cap
$4.81B
Change (1 day)
1.79%
Change (1 year)
-44.34%
Country
HK
Trade Regencell Bioscience Holdings Limited (RGC)
Category
Healthcare
EPS for Regencell Bioscience Holdings Limited (RGC)
EPS as of June 2026 TTM: $-0.02
According to Regencell Bioscience Holdings Limited latest financial reports and stock price the company's current EPS (TTM) is $-0.02. At the end of 2024 the company had a EPS of $-0.01 equal to its 2023 EPS that were of $-0.01.
EPS history for Regencell Bioscience Holdings Limited from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | 136.00% |
| 2025 | $-0.01 | -17.24% |
| 2024 | $-0.01 | -26.89% |
| 2023 | $-0.01 | -20.67% |
| 2022 | $-0.02 | 435.71% |
| 2021 | 0.00 | 64.71% |
| 2020 | 0.00 | 112.50% |
| 2019 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2,457.20% |
IN
|
